MAHT stands for Mild Hyperthermia Therapy. It is a medical treatment method that involves elevating the body’s temperature to a slightly higher-than-normal level (usually around 40-42°C or 104-107.6°F) for a specific period of time to achieve therapeutic benefits. Mild hyperthermia therapy is distinct from high fever, as it is carefully controlled and monitored by healthcare professionals to ensure safety and efficacy.
External Hyperthermia: External hyperthermia involves applying heat to the body’s surface using external devices, such as infrared lamps, radiofrequency devices, or microwave applicators. The heat penetrates the skin and underlying tissues to raise the temperature of the targeted area.
Regional Hyperthermia: Regional hyperthermia focuses heat on specific body regions or organs, such as the chest, abdomen, or pelvis, using specialized devices or applicators. This technique is often used in combination with other cancer treatments, such as radiation therapy or chemotherapy.
Whole-Body Hyperthermia: Whole-body hyperthermia involves raising the body’s core temperature to induce systemic effects. This approach is less commonly used and requires specialized equipment to heat the entire body evenly while monitoring vital signs closely.
Mild hyperthermia therapy is typically performed in a clinical setting under the supervision of trained healthcare professionals. Treatment parameters, such as temperature, duration, and frequency of sessions, are tailored to each patient’s individual needs and medical condition. Mild hyperthermia therapy may be used as a standalone treatment or in combination with other cancer therapies as part of a comprehensive treatment plan